Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute for Occupational Safety and Health (NIOSH), 37861 [2017-17130]

Download as PDF Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–17025 Filed 8–11–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee. This meeting is open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dial-in number at 1–866–659– 0537 and the pass code is 9933701. The conference line has 150 ports for callers. DATES: The meeting will be held on September 28, 2017, 10:30 a.m.–5:00 p.m., EDT. ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1–866–659–0537 and the pass code is 9933701. FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30333, Telephone (513) 533– 6800, Toll Free 1 (800) CDC–INFO, Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:24 Aug 11, 2017 Jkt 241001 new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2016 pursuant to Executive Order 13708, and will expire on September 30, 2017. Purpose: The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee for Dose Reconstruction Reviews was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. Matters To Be Considered: The agenda for the Subcommittee meeting includes the following dose reconstruction program quality management and assurance activities: Dose reconstruction cases under review from Sets 14–23, including the Oak Ridge sites (Y–12, K– 25, Oak Ridge National Laboratory), Hanford, Feed Materials Production Center (‘‘Fernald’’), Lawrence Livermore National Laboratory, Mound Plant, Rocky Flats Plant, Nevada Test Site, Idaho National Laboratory, Savannah River Site, Brookhaven National Laboratory, Westinghouse, W.R. Grace, Uranium Mill in Monticello, Ventron Corporation, Weldon Springs Plant, and other Department of Energy and ‘‘Atomic Weapons Employer’’ facilities. PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 37861 The agenda is subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–17130 Filed 8–11–17; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families [CFDA Numbers: 93.581, 93.587, 93.612] Request for Public Comment on the Proposed Adoption of Administration for Native Americans Program Policies and Procedures Administration for Native Americans, ACF, HHS. ACTION: Notice for public comment. AGENCY: Pursuant to Section 814 of the Native American Programs Act of 1974 (NAPA), as amended, the Administration for Native Americans (ANA) is required to provide members of the public an opportunity to comment on proposed changes in interpretive rules and general statements of policy and to give notice of the final adoption of such changes no less than 30 days before such changes become effective. In accordance with notice requirements of NAPA, ANA herein describes proposed interpretive rules and general statements of policy that relate to ANA’s funding opportunities beginning in Fiscal Year (FY) 2018. Changes to FY 2018 Funding Opportunity Announcements (FOAs) will be based on the following previously published programs: Environmental Regulatory Enhancement (ERE) HHS–2017–ACF–ANA–NR–1221, Native American Language Preservation and Maintenance-Esther Martinez Immersion (EMI) HHS–2017–ACF– ANA–NB–1226, Native American Language Preservation and Maintenance (P&M) HHS–2017–ACF–ANA–NL–1235, Social and Economic Development Strategies (SEDS) HHS–2017–ACF– ANA–NA–1236, Social and Economic Development Strategies-Alaska (SEDS– AK) HHS–2015–ACF–ANA–NK–0960, SUMMARY: E:\FR\FM\14AUN1.SGM 14AUN1

Agencies

[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Page 37861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17130]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or the 
Advisory Board), Subcommittee for Dose Reconstruction Reviews (SDRR), 
National Institute for Occupational Safety and Health (NIOSH)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting for the aforementioned subcommittee. This meeting is 
open to the public, but without a public comment period. The public is 
welcome to submit written comments in advance of the meeting, to the 
contact person below. Written comments received in advance of the 
meeting will be included in the official record of the meeting. The 
public is also welcome to listen to the meeting by joining the 
teleconference at the USA toll-free, dial-in number at 1-866-659-0537 
and the pass code is 9933701. The conference line has 150 ports for 
callers.

DATES: The meeting will be held on September 28, 2017, 10:30 a.m.-5:00 
p.m., EDT.

ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-
free dial-in number is 1-866-659-0537 and the pass code is 9933701.

FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal 
Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, Georgia 
30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, Email 
ocas@cdc.gov.

SUPPLEMENTARY INFORMATION: Background: The Advisory Board was 
established under the Energy Employees Occupational Illness 
Compensation Program Act of 2000 to advise the President on a variety 
of policy and technical functions required to implement and effectively 
manage the new compensation program. Key functions of the Advisory 
Board include providing advice on the development of probability of 
causation guidelines, which have been promulgated by the Department of 
Health and Human Services (HHS) as a final rule; advice on methods of 
dose reconstruction, which have also been promulgated by HHS as a final 
rule; advice on the scientific validity and quality of dose estimation 
and reconstruction efforts being performed for purposes of the 
compensation program; and advice on petitions to add classes of workers 
to the Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, rechartered on March 22, 2016 
pursuant to Executive Order 13708, and will expire on September 30, 
2017.
    Purpose: The Advisory Board is charged with (a) providing advice to 
the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class. The Subcommittee 
for Dose Reconstruction Reviews was established to aid the Advisory 
Board in carrying out its duty to advise the Secretary, HHS, on dose 
reconstruction.
    Matters To Be Considered: The agenda for the Subcommittee meeting 
includes the following dose reconstruction program quality management 
and assurance activities: Dose reconstruction cases under review from 
Sets 14-23, including the Oak Ridge sites (Y-12, K-25, Oak Ridge 
National Laboratory), Hanford, Feed Materials Production Center 
(``Fernald''), Lawrence Livermore National Laboratory, Mound Plant, 
Rocky Flats Plant, Nevada Test Site, Idaho National Laboratory, 
Savannah River Site, Brookhaven National Laboratory, Westinghouse, W.R. 
Grace, Uranium Mill in Monticello, Ventron Corporation, Weldon Springs 
Plant, and other Department of Energy and ``Atomic Weapons Employer'' 
facilities. The agenda is subject to change as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-17130 Filed 8-11-17; 8:45 am]
 BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.